{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T06:09:57Z","timestamp":1788934197865,"version":"build-2803163510"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","content-domain":{"domain":["ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.ejim.2013.08.711","type":"journal-article","created":{"date-parts":[[2013,9,23]],"date-time":"2013-09-23T17:59:38Z","timestamp":1379959178000},"page":"67-72","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":75,"title":["Mineralocorticoid receptor antagonism in acutely decompensated chronic heart failure"],"prefix":"10.1016","volume":"25","author":[{"given":"Jo\u00e3o Pedro","family":"Ferreira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1rio","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Marques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo","family":"Bettencourt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrique","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2013.08.711_bb0005","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1161\/CIRCULATIONAHA.104.500546","article-title":"Mechanisms and models in heart failure: the biomechanical model and beyond","author":"Mann","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2013.08.711_bb0010","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2013.08.711_bb0015","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1009492","article-title":"Eplerenone in patients with systolic heart failure and mild symptoms","volume":"364","author":"Zannad","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2013.08.711_bb0020","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.jacc.2008.10.041","article-title":"Acute heart failure syndromes","author":"Gheorghiade","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejim.2013.08.711_bb0025","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1093\/eurheartj\/ehr170","article-title":"Mineralocorticoid receptor antagonism: therapeutic potential in acute heart failure syndromes","author":"Albaghdadi","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejim.2013.08.711_bb0030","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0002-9149(02)03119-3","article-title":"Neurohormonal prediction of mortality following admission for decompensated heart failure","author":"Aronson","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ejim.2013.08.711_bb0035","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1161\/01.HYP.0000205224.58715.cc","article-title":"Rapid nongenomic effects of aldosterone on the renal vasculature in humans","author":"Schmidt","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.ejim.2013.08.711_bb0040","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1042\/cs1030425","article-title":"Aldosterone induces acute endothelial dysfunction in vivo in humans: evidence for an aldosterone-induced vasculopathy","volume":"103","author":"Farquharson","year":"2002","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.ejim.2013.08.711_bb0045","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s10741-007-9011-8","article-title":"Acute heart failure syndromes: clinical scenarios and pathophysiologic targets for therapy","volume":"12","author":"De Luca","year":"2007","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.ejim.2013.08.711_bb0050","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1067\/mhj.2002.129969","article-title":"Aldosterone: cardiovascular assault","author":"Struthers","year":"2002","journal-title":"Am Heart J"},{"key":"10.1016\/j.ejim.2013.08.711_bb0055","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"10.1016\/j.ejim.2013.08.711_bb0060","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1001\/jama.293.5.572","article-title":"Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis","author":"Fonarow","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.ejim.2013.08.711_bb0065","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1001\/jama.290.19.2581","article-title":"Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model","author":"Lee","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.ejim.2013.08.711_bb0070","doi-asserted-by":"crossref","first-page":"21A","DOI":"10.1016\/0002-9149(93)90241-4","article-title":"Spironolactone in congestive heart failure refractory to high-dose loop diuretic and low-dose angiotensin-converting enzyme inhibitor","volume":"71","author":"van Vliet","year":"1993","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ejim.2013.08.711_bb0075","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1161\/CIRCULATIONAHA.108.778811","article-title":"Serum potassium and clinical outcomes in the eplerenone post-acute myocardial infarction heart failure efficacy and survival study (ephesus)","author":"Pitt","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2013.08.711_bb0080","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1056\/NEJMoa1005419","article-title":"Diuretic strategies in patients with acute decompensated heart failure","volume":"364","author":"Felker","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2013.08.711_bb0085","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ahj.2003.08.012","article-title":"Relationship between heart failure treatment and development of worsening renal function among hospitalized patients","author":"Butler","year":"2004","journal-title":"Am Heart J"},{"key":"10.1016\/j.ejim.2013.08.711_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2005.07.067","article-title":"Role of diminished renal function in cardiovascular mortality: marker or pathogenetic factor?","author":"Schrier","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejim.2013.08.711_bb0095","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1440-1797.2007.00889.x","article-title":"The comparison of the diuretic and natriuretic efficacy of continuous and bolus intravenous furosemide in patients with chronic kidney disease","author":"Sanjay","year":"2008","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.ejim.2013.08.711_bb0100","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized aldactone evaluation study investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2013.08.711_bb0105","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1093\/eurheartj\/ehm091","article-title":"A propensity-matched study of the association of low serum potassium levels and mortality in chronic heart failure","author":"Ahmed","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejim.2013.08.711_bb0110","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1054\/jcaf.2000.8833","article-title":"Direct comparison between endothelin-1, n-terminal proatrial natriuretic factor, and brain natriuretic peptide as prognostic markers of survival in congestive heart failure","author":"Selvais","year":"2000","journal-title":"J Card Fail"},{"key":"10.1016\/j.ejim.2013.08.711_bb0115","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1161\/01.CIR.89.5.1934","article-title":"N-terminal proatrial natriuretic factor. An independent predictor of long-term prognosis after myocardial infarction","volume":"89","author":"Hall","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2013.08.711_bb0120","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/S0735-1097(01)01116-0","article-title":"Effect of spironolactone on plasma brain natriuretic peptide and left ventricular remodeling in patients with congestive heart failure","author":"Tsutamoto","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejim.2013.08.711_bb0125","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.ejheart.2007.05.007","article-title":"The role of plasma biomarkers in acute heart failure. Serial changes and independent prognostic value of nt-probnp and cardiac troponin-t","author":"Metra","year":"2007","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ejim.2013.08.711_bb0130","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1161\/01.CIR.0000144310.04433.BE","article-title":"N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients","author":"Bettencourt","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2013.08.711_bb0135","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00424-008-0616-0","article-title":"Actions of aldosterone in the cardiovascular system: the good, the bad, and the ugly?","volume":"458","author":"Gekle","year":"2009","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.ejim.2013.08.711_bb0140","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1042\/CS20070123","article-title":"Aldosterone and end-organ damage","author":"Marney","year":"2007","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.ejim.2013.08.711_bb0145","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1159\/000168356","article-title":"Aldosterone in congestive heart failure: analysis of determinants and role in sodium retention","volume":"11","author":"Hensen","year":"1991","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.ejim.2013.08.711_bb0150","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/1479-5876-9-180","article-title":"The use of plasma aldosterone and urinary sodium to potassium ratio as translatable quantitative biomarkers of mineralocorticoid receptor antagonism","author":"Eudy","year":"2011","journal-title":"J Transl Med"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620513009217?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620513009217?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,12]],"date-time":"2018-10-12T15:27:33Z","timestamp":1539358053000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620513009217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S0953620513009217"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2013.08.711","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mineralocorticoid receptor antagonism in acutely decompensated chronic heart failure","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2013.08.711","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}